Boron Neutron Capture Therapy (BNCT) Combined With Cetuximab in the Treatment of Locally Recurred Head and Neck Cancer

NCT00927147 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

TERMINATED

Status

17

Enrollment

INDUSTRY

Sponsor class

Stopped The neutron facility closed down for financial reasons.

Conditions

Head and Neck Cancer

Interventions

RADIATION: BNCT
DRUG: cetuximab

Sponsor

Boneca Corporation